Surgical stress and tumor behavior: Impact of ischemia-reperfusion and hepatic resection on tumor progression

Liver Transplantation

Volumn 13, Issue 12, 2007, Pages 1623-1626

  Ozaki, Michitaka ^a   Todo, Satoru ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINERGIC RECEPTOR; CYCLINE; EARLY GROWTH RESPONSE FACTOR 1; FOCAL ADHESION KINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; PROTEIN CDC42; RAC1 PROTEIN; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; RHO KINASE; SCATTER FACTOR; STAT3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN; XANTHINE OXIDASE;

APOPTOSIS; CANCER INVASION; CELL MIGRATION; CELL PROLIFERATION; DISEASE COURSE; EDITORIAL; ENZYME ACTIVATION; HUMAN; LIVER CARCINOGENESIS; LIVER INJURY; LIVER ISCHEMIA; LIVER NECROSIS; LIVER REGENERATION; LIVER RESECTION; LIVER TUMOR; METASTASIS; METASTASIS POTENTIAL; MITOCHONDRIAL RESPIRATION; NONHUMAN; OXIDATIVE STRESS; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPERFUSION INJURY; SIGNAL TRANSDUCTION; SURGICAL STRESS; TUMOR GROWTH;

ANIMALS; CDC42 GTP-BINDING PROTEIN; CELL ADHESION; CELL MOVEMENT; CELL PROLIFERATION; EARLY GROWTH RESPONSE PROTEIN 1; FOCAL ADHESION PROTEIN-TYROSINE KINASES; HEPATECTOMY; HUMANS; LIVER; LIVER NEOPLASMS; LUNG NEOPLASMS; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; PHOSPHORYLATION; RAC1 GTP-BINDING PROTEIN; REPERFUSION INJURY; RHO-ASSOCIATED KINASES; RISK FACTORS; RNA, MESSENGER; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 37549006777     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.21230     Document Type: Editorial

References (40)

1. Man K, Ng KT, Lo CM, Ho JW, Sun BS, Sun CK, et al. Ischemia-reperfusion of small liver remnant promotes liver tumor growth and metastases - activation of cell invasion and migration pathways. Liver Transpl 2007;13: 1669-1677.
2. Granger DN, Rutili G, McCord JM. Superoxide radicals in feline intestinal ischemia. Gastroenterology 1981;81:22-29.
3. Chambers DE, Parks DA, Patterson G, Roy R, McCord JM, Yoshida S, et al. Xanthine oxidase as a source of free radical damage in myocardial ischemia. J Mol Cell Cardiol 1985;17:145-152.
4. McCord JM. Oxygen-derived free radicals in postischemic tissue injury. N Engl J Med 1985;312:159-163.
5. Jaeschke H. Xanthine oxidase-induced oxidant stress during hepatic ischemia-reperfusion: are we coming full circle after 20 years? Hepatology 2002;36:761-63.
6. Taylor DE, Ghio AJ, Piantadosi CA. Reactive oxygen species produced by liver mitochondria of rats in sepsis. Arch Biochem Biophys 1995;316:70-76.
7. Littauer A, de Groot H. Release of reactive oxygen by hepatocytes on reoxygenation: three phases and role of mitochondria. Am J Physiol 1992;262(Pt 1):G1015-G1020.
8. Lambeth JD, NOX enzymes and the biology of reactive oxygen. Nat Rev Immunol 2004;4:181-189.
9. Suh YA, Arnold RS, Lassegue B, Shi J, Xu X, Sorescu D, et al. Cell transformation by the superoxide-generating oxidase Moxl. Nature 1999;401:79-82.
10. Irani K, Ma Y, Zweier JL, Sollott SJ, Der CJ, Fearon ER, et al. Mitogenic signaling mediated by oxidants in Ras-transformed fibroblasts. Science 1997;275:1649-1652.
11. Terui K, Haga S, Enosawa S, Ohnuma N, Ozaki M. Hypoxia/ re-oxygenation-induced, redox-dependent activation of STAT1 (signal transducer and activator of transcription 1) confers resistance to apoptotic cell death via hsp70 induction. Biochem J 2004:380(Pt 1):203-209.
12. Ozaki M, Haga S, Irani K, Amemiya H, Suzuki S. Overexpression of redox factor-1 protects against postischemic liver injury by reducing oxidative stress and NF-kappa B activity. Transplant Proc 2002;34:2640-2642.
13. Haga. S, Terui K, Zhang HQ, Enosawa S, Ogawa W, Inoue H, et al. Stat3 protects against Fas-induced liver injury by redox-dependent and -independent mechanisms. J Clin Invest 2003;112:989-998.
14. McLennan HR, Degli Esposti M. The contribution of mitochondrial respiratory complexes to the production of reactive oxygen species. J Bioenerg Biomembr 2000;32:153-162.
15. Sundaresan M, Yu ZX, Ferrans VJ, Irani K, Finkel T. Requirement for generation of H2O2 for platelet-derived growth factor signal transduction. Science 1995;270:296-299.
16. Ozaki M, Deshpande SS, Angkeow P, Bellan J, Lowenstein CJ, Dinauer MC, et al. Inhibition of the Rac1 GTPase protects against nonlethal ischemia/ reperfusion-induced necrosis and apoptosis in vivo. FASEB J 2000;14:418-429.
17. Ozaki M, Deshpande SS, Angkeow P, Suzuki S, Irani K. Rac1 regulates stress-induced, redox-dependent heat shock factor activation. J Biol Chem 2000;275:35377-35383.
18. Lesurtel M, Graf R, Aleil B, Walther DJ, Tian Y, Jochum W, et al. Platelet-derived scrotonin mediates liver regeneration. Science 2006;312:104-107.
19. Sorescu D, Weiss D, Lasseque B, Clempus RE, Szocs K, Sorescu GP, et al. Superoxide production and expression of nox family proteins in human atherosclerosis. Circulation 2002;105:1429-1435.
20. Monks NR, Biswas DK, Pardee AB. Blocking anti-apoptosis as a strategy for cancer chemotherapy: NF-kappaB as a target. J Cell Biochem 2004;92:646-650.
21. Kren L, Brazdil J, Hermanova M, Goncharuk VN, Kallakury BV, Kaur P, Ross JS. Prognostic significance of anti-apoptosis proteins survivin and bcl-2 in non-small cell lung carcinomas: a clinicopathologic study of 102 cases. Appl Immunohistochem Mol Morphol 2004;12:44-49.
22. Chiou SK, Jones MK, Tarnawski AS. Survivin - an anti-apoptosis protein: its biological roles and implications for cancer and beyond. Med Sci Monit 2003;9:PI25-PI29.
23. Taub R. Liver regeneration: from myth to mechanism. Nat Rev Mol Cell Biol 2004;5:836-847.
24. Diehl AM, Rai RM. Liver regeneration 3: regulation of signal transduction during liver regeneration. FASEB J 1996;10:215-227.
25. Diehl AM, Rai R. Review: regulation of liver regeneration by pro-inflammatory cytokines. J Gastroenterol Hepatol 1996;11:466-470.
26. Brenner DA. Signal transduction during liver regeneration. J Gastroenterol Hepatol 1998; 13(Suppl):S93-S95.
27. Sakaguchi T, Liu L. Hepatic branch vagotomy can block liver regeneration enhanced by ursodesoxycholic acid in 66% hepatectomized rats. Auton Neurosci 2002;99:54-57.
28. Ohtake M, Sakaguchi T, Yoshida K, Muto T. Hepatic branch vagotomy can suppress liver regeneration in partially hepatectomized rats. HPB Surg 1993;6:277-286.
29. Vatamaniuk MZ, Horyn OV, Vatamaniuk OK, Doliba NM. Acetylcholine affects rat liver metabolism via type 3 muscarinic receptors in hepatocytes. Life Sci 2003;72:1871-1882.
30. de Jonge WJ, van der Zanden EP, The FO, Bijlsma MF, van Westerloo DJ, Bermink RJ, et al. Stimulation of the vagus nerve attenuates macrophage activation by activating the Jak2-STAT3 signaling pathway. Nat Immunol 2005;6:844-851.
31. Serobyan N, Schraufstatter IU, Strongin A, Khaldoyanidi SK. Nicotinic acetylcholine receptor-mediated stimulation of endothelial cells results in the arrest of haematopoietic progenitor cells on endothelium. Br J Haematol 2005;129: 257-265.
32. Rossmanith W, Schulte-Hermann R. Biology of transforming growth factor beta in hepatocarcinogenesis. Microsc Res Tech 2001;52:430-436.
33. Budhu A, Wang XW. The role of cytokines in hcpatocellular carcinoma. J Leukoc Biol 2006;80:1197-1213.
34. Durai R, Yang W, Gupta S, Seifalian AM, Winslet MC. The role of the insulin-like growth factor system in colorectal cancer: review of current knowledge. Int J Colorectal Dis 2005;20:203-220.
35. Ahmed SM, Salgia R. Epidermal growth factor receptor mutations and susceptibility to targeted therapy in lung cancer. Respirology 2006;11:687-692.
36. Sledge GW. VEGF-targeting therapy for breast cancer. J Mammary Gland Biol Neoplasia 2005;10:319-323.
37. van Horssen R, Ten Hagen TL, Eggermont AM. TWF-alpha in cancer treatment: molecular insights, antitumor effects, and clinical utility. Oncologist 2006:11:397-408.
38. Jaouen G, Top S, Vessieres A, Leclereq G, McGlinchey MJ. The first organometallic selective estrogen receptor modulators (SERMs) and their relevance to breast cancer. Curr Med Chem 2004;11:2505-2517.
39. Carruba G. Estrogens and mechanisms of prostate cancer progression. Ann NY Acad Sci 2006;1089:201-217.
40. Peant B, Diallo JS, Lessard L, Delvoye N, Le Page C, Saad F, Mes-Masson AM. Regulation of I{kappa}B kinase {varepsilon} expression by the androgen receptor and the nuclear factor-{kappa}B transcription factor in prostate cancer. Mol Cancer Res 2007;5:87-94.